Found: 61
Select item for more details and to access through your institution.
Health Technology Assessment in the US—A Word of Caution—Reply.
- Published in:
- JAMA Internal Medicine, 2024, v. 184, n. 7, p. 851, doi. 10.1001/jamainternmed.2024.1461
- By:
- Publication type:
- Article
Availability and Coverage of New Drugs in 6 High-Income Countries With Health Technology Assessment Bodies.
- Published in:
- JAMA Internal Medicine, 2024, v. 184, n. 3, p. 328, doi. 10.1001/jamainternmed.2023.7726
- By:
- Publication type:
- Article
Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Estimated Medicare Spending on Cancer Drug Indications With a Confirmed Lack of Clinical Benefit After US Food and Drug Administration Accelerated Approval.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Communication of Survival Data in US Food and Drug Administration-Approved Labeling of Cancer Drugs.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Coverage in England of US-Approved Cancer Drugs-Reply.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Assessment of Devices, Diagnostics and Digital Technologies: A Review of NICE Medical Technologies Guidance.
- Published in:
- Applied Health Economics & Health Policy, 2019, v. 17, n. 2, p. 189, doi. 10.1007/s40258-018-0438-y
- By:
- Publication type:
- Article
ENERJİ VE ELEKTRİK KULLANIMININ TÜRKİYE EKONOMİSİ ÜZERİNDEKİ ETKİSİ.
- Published in:
- International Journal of Management Economics & Business / Uluslararası Yönetim İktisat ve İşletme Dergisi, 2021, v. 17, n. 2, p. 317, doi. 10.17130/ijmeb.807469
- By:
- Publication type:
- Article
Improving health care services in Northern Cyprus: a call for research and action.
- Published in:
- European Journal of Public Health, 2012, v. 22, n. 6, p. 754, doi. 10.1093/eurpub/cks145
- By:
- Publication type:
- Article
Planning a future randomized clinical trial based on a network of relevant past trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Correction: An Assessment of the Methodological Quality of Published Network Meta-Analyses: A Systematic Review.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0131953
- By:
- Publication type:
- Article
An Assessment of the Methodological Quality of Published Network Meta-Analyses: A Systematic Review.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0121715
- By:
- Publication type:
- Article
Avoidable costs of stenting for aortic coarctation in the United Kingdom: an economic model.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The impact of post-procedural complications on reimbursement, length of stay and mechanical ventilation among patients undergoing transcatheter aortic valve implantation in Germany.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Availability of New Medicines in the US and Germany From 2004 to 2018.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 9, p. e2229231, doi. 10.1001/jamanetworkopen.2022.29231
- By:
- Publication type:
- Article
Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 8, p. e2225973, doi. 10.1001/jamanetworkopen.2022.25973
- By:
- Publication type:
- Article
OP440 Comparison Of Evidence Supporting Cancer Drug Approvals And Prices In The US And Brazil.
- Published in:
- International Journal of Technology Assessment in Health Care, 2021, v. 37, n. S1, p. 16, doi. 10.1017/S0266462321001057
- By:
- Publication type:
- Article
Assessment of technical errors and validation processes in economic models submitted by the company for NICE technology appraisals.
- Published in:
- 2020
- By:
- Publication type:
- journal article
NICE's evaluations of medicines authorized by EMA with conditional marketing authorization or under exceptional circumstances.
- Published in:
- 2020
- By:
- Publication type:
- journal article
OECD Ülkelerinde Biyoyakıt Politikalarının Ulaşım Sektöründeki Petrol Tüketimine Etkisi.
- Published in:
- Journal of Economics & Administrative Sciences / Eskisehir Osmangazi Universitesi Iktisadi ve Idari Bilimler Fakultesi Dergisi, 2020, v. 15, n. 3, p. 811, doi. 10.17153/oguiibf.525504
- By:
- Publication type:
- Article
Uluslararası Doğalgaz Piyasasının Ekonomik Yapısı ve Uygulanan Politikalar.
- Published in:
- Journal of Economics & Administrative Sciences / Eskisehir Osmangazi Universitesi Iktisadi ve Idari Bilimler Fakultesi Dergisi, 2018, v. 13, n. 3, p. 13, doi. 10.17153/oguiibf.405932
- By:
- Publication type:
- Article
Association Between Preapproval Confirmatory Trial Initiation and Conversion to Traditional Approval or Withdrawal in the FDA Accelerated Approval Pathway.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 9, p. 760, doi. 10.1001/jama.2023.0625
- By:
- Publication type:
- Article
Capsule Commentary on Ott et al., Do Statins Impair Cognition? A Systematic Review and Meta-analysis of Randomized Controlled Trials.
- Published in:
- JGIM: Journal of General Internal Medicine, 2015, v. 30, n. 3, p. 347, doi. 10.1007/s11606-014-3158-5
- By:
- Publication type:
- Article
History Bias, Study Design, and the Unfulfilled Promise of Pay-for-Performance Policies in Health Care.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparison of Uptake and Prices of Biosimilars in the US, Germany, and Switzerland.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 12, p. e2244670, doi. 10.1001/jamanetworkopen.2022.44670
- By:
- Publication type:
- Article
ORTA DOĞU ENERJİ KAYNAKLARININ BÖLGE ÜLKELERİNİN EKONOMİK BÜYÜMESİ ÜZERİNDEKİ ETKİSİNİN ANALİZİ.
- Published in:
- Firat University Journal of Social Sciences / Firat Üniversitesi Sosyal Bilimler Dergisi, 2022, v. 32, n. 2, p. 579, doi. 10.18069/firatsbed.1015536
- By:
- Publication type:
- Article
OICA Üyesi AB (14) Ülkelerinde İnovasyon Belirleyicilerinin Otomotiv Sektörü Rekabet Gücü Üzerindeki Etkisi.
- Published in:
- Çankırı Karatekin University Journal of the Faculty of Economics & Administrative Sciences, 2023, v. 13, n. 2, p. 633, doi. 10.18074/ckuiibfd.1199305
- By:
- Publication type:
- Article
Combining Multiple Treatment Comparisons with Personalized Patient Preferences: A Randomized Trial of an Interactive Platform for Statin Treatment Selection.
- Published in:
- Medical Decision Making, 2019, v. 39, n. 3, p. 264, doi. 10.1177/0272989X19835239
- By:
- Publication type:
- Article
Personalizing Second-Line Type 2 Diabetes Treatment Selection: Combining Network Meta-analysis, Individualized Risk, and Patient Preferences for Unified Decision Support.
- Published in:
- Medical Decision Making, 2019, v. 39, n. 3, p. 239, doi. 10.1177/0272989X19829735
- By:
- Publication type:
- Article
Applying Multiple Criteria Decision Analysis to Comparative Benefit-Risk Assessment.
- Published in:
- Medical Decision Making, 2015, v. 35, n. 7, p. 859, doi. 10.1177/0272989X15587005
- By:
- Publication type:
- Article
Impact of predictive medicine on therapeutic decision making: a randomized controlled trial in congenital heart disease.
- Published in:
- NPJ Digital Medicine, 2019, v. 2, p. N.PAG, doi. 10.1038/s41746-019-0085-1
- By:
- Publication type:
- Article
Treatment methods for cervical intraepithelial neoplasia in England: A cost‐effectiveness analysis.
- Published in:
- BJOG: An International Journal of Obstetrics & Gynaecology, 2024, v. 131, n. 10, p. 1411, doi. 10.1111/1471-0528.17829
- By:
- Publication type:
- Article
Unintended Consequences of Coverage Laws Targeting Cancer Drugs.
- Published in:
- Journal of Law, Medicine & Ethics, 2020, v. 48, n. 3, p. 552, doi. 10.1177/1073110520958880
- By:
- Publication type:
- Article
Economic burden of multiple sclerosis: a systematic review of the literature.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Economic Burden of Multiple Sclerosis.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 5, p. 363, doi. 10.2165/11532230-000000000-00000
- By:
- Publication type:
- Article
Post‐Marketing Requirements for Cancer Drugs Approved by the European Medicines Agency, 2004–2014.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 4, p. 846, doi. 10.1002/cpt.2679
- By:
- Publication type:
- Article
Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 2, p. 350, doi. 10.1002/cpt.1835
- By:
- Publication type:
- Article
European Medicines Agency's Priority Medicines Scheme at 2 Years: An Evaluation of Clinical Studies Supporting Eligible Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 3, p. 541, doi. 10.1002/cpt.1669
- By:
- Publication type:
- Article
Coverage of New Drugs in Medicare Part D.
- Published in:
- Milbank Quarterly, 2022, v. 100, n. 2, p. 562, doi. 10.1111/1468-0009.12565
- By:
- Publication type:
- Article
Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United States.
- Published in:
- Milbank Quarterly, 2020, v. 98, n. 4, p. 1219, doi. 10.1111/1468-0009.12476
- By:
- Publication type:
- Article
Timing and Characteristics of Cumulative Evidence Available on Novel Therapeutic Agents Receiving Food and Drug Administration Accelerated Approval.
- Published in:
- Milbank Quarterly, 2017, v. 95, n. 2, p. 261, doi. 10.1111/1468-0009.12261
- By:
- Publication type:
- Article
Treatment Effects in Randomized and Nonrandomized Studies of Pharmacological Interventions: A Meta-Analysis.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 9, p. e2436230, doi. 10.1001/jamanetworkopen.2024.36230
- By:
- Publication type:
- Article
Recalibrating Health Technology Assessment Methods for Cell and Gene Therapies.
- Published in:
- PharmacoEconomics, 2020, v. 38, n. 12, p. 1297, doi. 10.1007/s40273-020-00956-w
- By:
- Publication type:
- Article
Evidence Required for Drugs Granted Accelerated Approval-Reply.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Regulators Should Better Leverage Effectiveness Standards to Enhance Drug Value.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 10, p. 1005, doi. 10.1002/phar.1467
- By:
- Publication type:
- Article
Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D.
- Published in:
- JAMA Health Forum, 2023, v. 4, n. 2, p. e225610, doi. 10.1001/jamahealthforum.2022.5610
- By:
- Publication type:
- Article
Negotiating Drug Prices in the US—Lessons From Europe.
- Published in:
- 2022
- By:
- Publication type:
- Opinion
NITRATE-CIN Study: Protocol of a Randomized (1:1) Single-Center, UK, Double-Blind Placebo-Controlled Trial Testing the Effect of Inorganic Nitrate on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography for Acute Coronary Syndromes.
- Published in:
- 2021
- By:
- Publication type:
- journal article